Search research articles
Contact Us
Filters
Showing results (411-420 of 487) with videos related to
Page
of 49
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2016
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells
Chad Tang, James W Welsh, Patricia de Groot, et al.
Med (New York, N.Y.)
|
June 28, 2025
Plinabulin following radiation enhances dendritic cell maturation and checkpoint inhibitor retreatment of relapsed/refractory cancers
Steven H Lin, Vivek Subbiah, Evan N Cohen, et al.
Journal of Hematology & Oncology
|
June 12, 2015
STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion
Vivek Subbiah, Caitlin McMahon, Shreyaskumar Patel, et al.
Cancer
|
October 20, 2015
Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies
Rami N Al-Rohil, Ashley J Tarasen, J Andrew Carlson, et al.
Cancer Discovery
|
October 13, 2016
Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation
David S Hong, Van K Morris, Badi El Osta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa
Walter O Mwanda, Jackson Orem, Pingfu Fu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 8, 2022
Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction
Pei Jye Voon, Eric X Chen, Helen X Chen, et al.
NPJ Precision Oncology
|
March 20, 2021
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study
Apostolia Maria Tsimberidou, David S Hong, Siqing Fu, et al.
JAMA Oncology
|
December 1, 2017
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study
Eli L Diamond, Vivek Subbiah, A Craig Lockhart, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials
Dario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Page
of 49
Search research articles
Search
Showing results (411-420 of 487) with videos related to
Sort By:
Page
of 49
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2016
Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells
Chad Tang, James W Welsh, Patricia de Groot, et al.
Med (New York, N.Y.)
|
June 28, 2025
Plinabulin following radiation enhances dendritic cell maturation and checkpoint inhibitor retreatment of relapsed/refractory cancers
Steven H Lin, Vivek Subbiah, Evan N Cohen, et al.
Journal of Hematology & Oncology
|
June 12, 2015
STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion
Vivek Subbiah, Caitlin McMahon, Shreyaskumar Patel, et al.
Cancer
|
October 20, 2015
Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies
Rami N Al-Rohil, Ashley J Tarasen, J Andrew Carlson, et al.
Cancer Discovery
|
October 13, 2016
Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation
David S Hong, Van K Morris, Badi El Osta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa
Walter O Mwanda, Jackson Orem, Pingfu Fu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 8, 2022
Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction
Pei Jye Voon, Eric X Chen, Helen X Chen, et al.
NPJ Precision Oncology
|
March 20, 2021
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study
Apostolia Maria Tsimberidou, David S Hong, Siqing Fu, et al.
JAMA Oncology
|
December 1, 2017
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study
Eli L Diamond, Vivek Subbiah, A Craig Lockhart, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials
Dario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Page
of 49